Literature DB >> 21468011

IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.

Delia Zanzi1, Rosita Stefanile, Sara Santagata, Laura Iaffaldano, Gaetano Iaquinto, Nicola Giardullo, Giuliana Lania, Ilaria Vigliano, Aufiero Rotondi Vera, Katia Ferrara, Salvatore Auricchio, Riccardo Troncone, Giuseppe Mazzarella.   

Abstract

OBJECTIVES: Celiac disease (CD) is a condition in which the regulation of the mucosal immune response to dietary gliadin might be altered. The transcription factor forkhead box P3 (Foxp3) has been identified as a marker of a subset of regulatory T cells (Treg). In this study, we have investigated the presence and the suppressive function of Treg cells in the celiac small intestinal mucosa, their correlation with the disease state, and the inducibility by gliadin in an organ culture system; moreover, we tried to define whether interleukin 15 (IL-15), overexpressed in CD, could influence the regulatory activity of such cells.
METHODS: The expression of Foxp3, CD3, CD4, and CD8 were analyzed by immunohistochemistry and flow cytometry in duodenal biopsies taken from patients with untreated CD, treated CD, and from non-CD controls, as well as in vitro cultured biopsy samples from treated CD patients, upon challenge with gliadin. Furthermore, we analyzed the suppressive function of CD4+CD25+ T cells, isolated from untreated CD biopsy samples, on autologous responder CD4+CD25- T cells, in the presence of a polyclonal stimulus, with or without IL-15.
RESULTS: Higher density of CD4+CD25+Foxp3+ T cells was seen in duodenal biopsy samples from active CD patients in comparison with treated CD and non-CD controls. In coculture, CD4+CD25+ T cells were functionally suppressive, but their activity was impaired by IL-15. Cells from CD subjects showed increased sensitivity to the IL-15 action, likely due to enhanced expression of IL-15 receptor. Finally, we demonstrated an expansion of Foxp3 in treated CD mucosa following in vitro challenge with gliadin.
CONCLUSIONS: These data suggest that CD4+CD25+Foxp3+ T cells are induced in situ by gliadin. However, their suppressor capacity might be impaired in vivo by IL-15; this phenomenon contributes to maintain and expand the local inflammatory response in CD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468011     DOI: 10.1038/ajg.2011.80

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  35 in total

Review 1.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

2.  Immunopathogenesis of olmesartan-associated enteropathy.

Authors:  E V Marietta; A M Nadeau; A K Cartee; I Singh; A Rishi; R S Choung; T-T Wu; A Rubio-Tapia; J A Murray
Journal:  Aliment Pharmacol Ther       Date:  2015-10-01       Impact factor: 8.171

Review 3.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

Review 4.  Effector and suppressor T cells in celiac disease.

Authors:  Giuseppe Mazzarella
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

5.  Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma.

Authors:  Serena K Perna; Biagio De Angelis; Daria Pagliara; Sayyeda T Hasan; Lan Zhang; Aruna Mahendravada; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Gianpietro Dotti; Barbara Savoldo
Journal:  Clin Cancer Res       Date:  2012-11-13       Impact factor: 12.531

6.  In the Intestinal Mucosa of Children With Potential Celiac Disease IL-21 and IL-17A are Less Expressed than in the Active Disease.

Authors:  Melissa Borrelli; Carmen Gianfrani; Giuliana Lania; Rosita Aitoro; Katia Ferrara; Merlin Nanayakkara; Domenico Ponticelli; Delia Zanzi; Valentina Discepolo; Serena Vitale; Maria Vittoria Barone; Riccardo Troncone; Renata Auricchio; Mariantonia Maglio
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

Review 7.  Latest in vitro and in vivo models of celiac disease.

Authors:  Samantha Stoven; Joseph A Murray; Eric V Marietta
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

8.  Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.

Authors:  Tiina Rauhavirta; Mikko Oittinen; Rami Kivistö; Pekka T Männistö; J Arturo Garcia-Horsman; Zhuo Wang; Martin Griffin; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  J Clin Immunol       Date:  2012-08-10       Impact factor: 8.317

9.  Human monocytes have increased IFN-γ-mediated IL-15 production with age alongside altered IFN-γ receptor signaling.

Authors:  Naeun Lee; Min Sun Shin; Ki Soo Kang; Seung-Ah Yoo; Subhasis Mohanty; Ruth R Montgomery; Albert C Shaw; Insoo Kang
Journal:  Clin Immunol       Date:  2014-03-19       Impact factor: 3.969

10.  IL-15 trans-presentation regulates homeostasis of CD4(+) T lymphocytes.

Authors:  Xi-Lin Chen; Diwakar Bobbala; Yuneivy Cepero Donates; Marian Mayhue; Subburaj Ilangumaran; Sheela Ramanathan
Journal:  Cell Mol Immunol       Date:  2014-03-24       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.